| abstract |
The present invention relates to a novel compound or a pharmaceutically acceptable salt thereof, a method for preparing the same, and a pharmaceutical composition for treating metabolic related disorders including the same. Specifically, the present invention relates to a compound of Formula 1, wherein the compound activates GPR119 to cause metabolic related disorders, namely diabetes and related diseases, microvascular complications associated with diabetes, macrovascular complications associated with diabetes, cardiovascular abnormalities, metabolic syndrome and its composition. It can be used to treat diseases, obesity and the like. [Formula 1] In Formula 1, X 1 , X 2 , Y 1 , Y 2 , L 1 , R 4 , n, Z 1 , Z 2 , Z 3 , Z 4 , P 1 and P 2 are as defined above. |